Allocations
SEA Medical Systems, a healthtech company focused on safety and management of IV medicine, has closed a USD3 million Series B investment with Chicago-based venture capital firm JK&B Capital, which specialises in investments in Information Technologies, healthcare and communication markets.
As part of the agreement, Chairman of JK&B Capital David Kronfeld, and Quantum Technology Partners’ Barry Dickman joined SEA Medical’s board of directors. Proceeds from this investment will allow SEA Medical to accelerate development of its IV products and expand its technology into additional medical applications.
"Thousands of people are killed or seriously injured in US hospitals each year when
Renaissance Asset Managers (RAM) has acquired the investment management mandate for two further Emerging European funds within Griffin Umbrella Fund plc with assets totalling USD116m. This development follows the acquisition of the Griffin Eastern European Fund with assets of USD252m, one of the oldest and best established funds in the emerging markets universe, announced in December 2011. Following this final transaction, total RAM assets under management will rise from USD2.4bn to USD2.8bn.
RAM is taking on takes on the management of the Griffin Ottoman Fund, a UCITS IV equities strategy with a focus on Turkey and broad Eastern European and
SquareTrade, the independent consumer warranty provider, has secured a USD238 million growth equity investment led by affiliates of Bain Capital. Other financial terms of the private transaction have not been disclosed.
“We are very excited to partner with SquareTrade, which is disrupting a USD20+ billion global industry with its innovative approach to warranties.” says Mike Krupka, a Managing Director of Bain Capital Ventures.
“We were attracted by the incredibly high satisfaction levels among consumers and retailers, along with the vision of co-founders Steve Abernethy and Ahmed Khaishgi, and their ability to execute the plan to build the first great brand
Channel Islands law firm Carey Olsen has advised Colfax UK Holdings Limited on its acquisition of Charter International plc through a Jersey scheme of arrangement. This deal is believed to be the largest transaction of its kind in Jersey with an estimated value of USD2.426 billion in cash and stock (approximately GBP1.528 billion) which is based on the closing price of GBP23.04 per Colfax share on 9 September, 2011.
Colfax UK Holdings Limited is a subsidiary of Colfax Corporation, a US-based international industrial group listed on the New York Stock Exchange.
A Carey Olsen cross practice team was instructed by,
GenNx360 Capital Partners (GenNx360) has formed GenNx360 India Advisors Private Limited. The new entity will operate out of two offices located in Gurgaon and Bangalore, India.
“This entity in India is the next logical step in our growth strategy of building a world-class, global organisation," says Jim Shepard, Managing Partner. "India has become one of the most vibrant and important finance and services hubs in the world. Our goal is to take advantage of the rich talent base in both financial and operating skills in India."
GenNx360 launched in 2006, and during GenNx360’s accelerated build-out of its team, Genpact has been
Global asset manager Capital Dynamics AG has sold its co-investment in Permasteelisa alongside lead investor Alpha Private Equity Fund 5, realising a multiple of investment cost of three times and a gross IRR of approximately 100%.
The successful exit was achieved by way of a trade sale to JS Group Corporation, a Japanese construction and building materials conglomerate with approximately EUR 8.5 billion in revenues. Completion of the exit took place in December, 2011 following receipt of anti-trust approvals. Permasteelisa is the world’s largest player in the engineering, manufacture and installation of architectural envelopes known as “curtain walls”. The company
The Amplio Group’s solar subsidiary, Amplio Solar, has secured EUR16 million in financing from a leading Italian bank to invest in 7 MW of solar plants in the Italian province of Latina, Lazio. This expansion brings Amplio Solar’s fully operational solar portfolio to over 30 MW, with a total investment to date of approximately EUR120 million.
Amplio Solar has built and project financed the 7 MW of solar plants in Latina, Lazio, with Rios Renovables of Spain as Engineering, Procurement and Construction (“EPC”) contractor. This latest investment underlines a successful 18 months for Amplio Solar, a period in which it
CN Creative, Ltd (CNC) has raised GBP2 million (USD3.1 million) in a Series A financing round led by Advent Life Sciences. The funds will be used to continue and finalise development of CNC’s Nicadex, a medically approved, electronic nicotine replacement inhaler.
Despite large-scale public health efforts, about 20% of adults in the UK and the US continue to smoke. Smoking remains the most common cause of preventable death in the Western world and generates enormous costs for healthcare systems worldwide. Two-thirds of smokers report that they would like to quit, and about three-quarters of current smokers say they have tried to
Dunedin-backed Hawksford is now the largest independent trust company in Jersey following its acquisition of Trustcorp Jersey Limited (Trustcorp), a Jersey based trust and corporate services provider.
This is the eleventh acquisition made by a Dunedin backed business in the last twelve months and is a prime example of Dunedin’s buy and build strategy of backing businesses with international growth opportunities.
The acquisition forms a significant part of the company’s growth strategy and follows recent expansion into the Middle East and Switzerland. Hawksford opened its Dubai office in June 2011 and acquired L-S&S GmbH, a Zurich boutique private wealth law
Mevion Medical Systems has closed a USD45 Million investment from ProQuest Investments and its existing investors, including Caxton Heath Life Sciences, Venrock and CHL Medical Partners.
Mevion is the manufacturer of the MEVION S250 Proton Therapy System. The capital will be used to accelerate the manufacturing and worldwide deployment of the MEVION S250.
Proton beam radiation therapy permits more precise dose targeting by complete proton absorption at predictable tissue depth, allowing the treatment of target volumes adjacent to critical structures without inadvertent dose to sensitive structures. The availability of proton therapy has remained very limited however, due to the enormous
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
